Skip to main content
OpenTrials

Clinical trial condition

Peripheral Nervous System Neoplasms

Explore clinical trials studying Peripheral Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

257 public trials 48 recruiting studies
Refine in advanced search Browse all conditions

Peripheral Nervous System Neoplasms trial results

Completed

SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors

NCT01661283

Conditions
Fibrosarcoma, MPNST, Malignant Peripheral Nerve Sheath Tumors, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Ann and Robert Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1

NCT02096471

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • Indiana Unversity Indianapolis, Indiana, United States
View Trial Details
Completed

Trial of Dasatinib in Advanced Sarcomas

NCT00464620

Conditions
Chondrosarcoma, Chordoma, Digestive System Diseases, +37 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Cedars-Sinai Outpatient Cancer Center Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
View all 20 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

NCT00304083

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, Genetic Diseases, Inborn, +22 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Children's Memorial Hospital - Chicago Chicago, Illinois, United States
  • Indiana University Indianapolis, Indiana, United States
View all 17 locations
View Trial Details
Completed

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

NCT01207687

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • National Cancer Institute Rockville, Maryland, United States
  • Massachusetts General Hospital Charlestown, Massachusetts, United States
View Trial Details

Related conditions